Influence of Cytokine Release Syndrome in Severe COVID-19 Patients Treated With Tocilizumab Over the Quantiferon TB Gold Plus Results

Detalles Bibliográficos
Autores principales: Sánchez-Martínez, Francesca, Arenas-Miras, Mar, Jové-Caballé, Neus, Knobel-Freud, Hernando
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SEPAR. Published by Elsevier España, S.L.U. 2021
Materias:
Scientific Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7881697/
https://www.ncbi.nlm.nih.gov/pubmed/34629655
http://dx.doi.org/10.1016/j.arbres.2021.02.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7881697/
https://www.ncbi.nlm.nih.gov/pubmed/34629655
http://dx.doi.org/10.1016/j.arbres.2021.02.003

Ejemplares similares